Gout is an acute rheumatic disorder that occurs in connection with the
deposition of monosodium urate (MSU) crystals in the joints. This dis
ease is characterized by intermittent episodes of severe pain and infl
ammatory joint swelling which are seemingly driven by prostaglandins.
In this study we investigated the effect of MSU crystals on arachidoni
c acid (AA) metabolism in the mouse. We have demonstrated that prostag
landins and other AA metabolites were transiently formed after MSU cry
stal injection with peak levels occurring after 10 min. In contrast, f
ree AA levels remained high for 2-4 hours after MSU crystal injection.
By contrast, when exogenous AA was administered instead of MSU crysta
ls, both the eicosanoids and AA diminished at the same high rates. The
metabolism of exogenously administered AA to eicosanoids was inhibite
d by pretreatment with MSU crystals. No inhibition of AA metabolism wa
s observed when mice were pretreated with AA itself, Ca2+ ionophore (A
23187), or zymosan. We conclude that the MSU crystal treatment of mice
results in a transient eicosanoid production which is followed by att
enuated AA metabolism. It could be that MSU crystals similarly inhibit
AA metabolism in gout and thereby limit the duration of gout attacks.